MARKET

ATRX

ATRX

Adhera Therapeutics Inc
EXMKT
0.0001
NaN%
Closed 09:30 01/16 EST
OPEN
--
PREV CLOSE
0.0001
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
4.526
52 WEEK LOW
0.0001
MARKET CAP
722.09
P/E (TTM)
-0.0001
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ATRX last week (0112-0116)?
Weekly Report · 6h ago
Weekly Report: what happened at ATRX last week (0105-0109)?
Weekly Report · 01/12 10:17
Weekly Report: what happened at ATRX last week (1229-0102)?
Weekly Report · 01/05 10:12
Weekly Report: what happened at ATRX last week (1222-1226)?
Weekly Report · 12/29/2025 10:11
Weekly Report: what happened at ATRX last week (1215-1219)?
Weekly Report · 12/22/2025 10:11
Weekly Report: what happened at ATRX last week (1208-1212)?
Weekly Report · 12/15/2025 10:18
Weekly Report: what happened at ATRX last week (1201-1205)?
Weekly Report · 12/08/2025 10:16
Weekly Report: what happened at ATRX last week (1124-1128)?
Weekly Report · 12/01/2025 10:12
More
About ATRX
Adhera Therapeutics, Inc. is a specialty biotech company. The Company is focused on the drug development and commercialization of small molecule drugs to treat Parkinson's disease (PD) and Type 1 diabetes. The Company has two drug candidates: MLR-1019 and MLR-1023. It is engaged in developing MLR-1023 (tolimidone) as a new drug for Type I Diabetes with a focus on C-peptide positive patients. Adhera also has exclusive rights to develop MLR-1023 for Non-Alcoholic Steatohepatitis (NASH) and pulmonary inflammation diseases and conditions. MLR-1023, a lyn kinase activator, has demonstrated clinical safety and tolerability in over 700 patients in Phase IIa and Phase IIb Type 2 diabetes studies. MLR-1019 (armesocarb) is a new class of drug for Parkinson's Disease.

Webull offers Adhera Therapeutics Inc stock information, including EXMKT: ATRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ATRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ATRX stock methods without spending real money on the virtual paper trading platform.